首页> 外文期刊>Haematologica >Tumor burden and serum level of soluble CD25, CD8, CD23, CD54 and CD44 in non-Hodgkin's lymphoma | Haematologica
【24h】

Tumor burden and serum level of soluble CD25, CD8, CD23, CD54 and CD44 in non-Hodgkin's lymphoma | Haematologica

机译:非霍奇金淋巴瘤的肿瘤负荷和血清可溶性CD25,CD8,CD23,CD54和CD44水平血液学

获取原文
           

摘要

We studied the value of soluble CD25, CD8, CD23, CD54 and CD44 serum levels as tumor burden markers in lymphoma. Soluble CD25 compared with the others sCD and the usual serum factors (albumin, lactate dehydrogenase, beta 2-microglobulin, uric acid and C-reactive protein), showed the strongest correlation with the Ann Arbor stage and the number of affected localizations. sCD25 level is the most sensitive serum marker for tumor burden in lymphoma.
机译:我们研究了可溶性CD25,CD8,CD23,CD54和CD44血清水平作为淋巴瘤中肿瘤负荷标志物的价值。与其他sCD和通常的血清因子(白蛋白,乳酸脱氢酶,β2-微球蛋白,尿酸和C反应蛋白)相比,可溶性CD25与Ann Arbor阶段和受影响的定位数目最相关。 sCD25水平是淋巴瘤最敏感的血清标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号